2-((2S,4R)-4-Hydroxypyrrolidin-2-yl)acetic acid hydrochloride, 95.0%, 100mg

2,4-Dichloro-6-(2-chlorophenyl)pyrimidine, 98%, 100mg

4,4'-(Anthracene-9,10-diyl)dibenzoic acid, 98%, 250mg

(S)-Dimethyl pyrrolidine-1,2-dicarboxylate, 95+%, 250mg

4-Iodo-2-(1-piperidinyl)pyridine, 95+%, 5g

5-Chloro-4-(difluoromethyl)-2,3-difluoropyridine, 1g

PYRIMIDINE, 4,5-DIMETHOXY- (9CI), 95.0%, 1g

Glass vials with rolled rim brown glass, 25 ml, Height, 50 mm, 200 Piece(s)

Methyl 4-(Aminomethyl)cyclohexanecarboxylate Hydrochloride (cis- and trans- mixture)>98.0%(T)5g

(2-phenyl-1,3-thiazol-5-yl)methanol, 1g

tert-Butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate, 97%, 2.5g

2,5-Di(1H-imidazol-1-yl)terephthalic acid, 98%, 250mg

D-Homophenylalanine>98.0%(T)1g